In The Newsalzheon2024-08-09T11:20:07-04:00

In the News

AAIC: A Pill to Slow Down Alzheimer’s Is About Two Years Away

beingpatient.com

Venture Capitalists Fund New Generation of Alzheimer’s Drugs

WSJ

Understanding Patient Characteristics of Phase 3 APOLLOE4 Trial of ALZ-801 in Alzheimer Disease: John Hey, PhD

NeurologyLive

Eli Lilly’s Donanemab: The Anti-Amyloid Saga Continues

Seeking Alpha

AAN 2023: ALZ-801 for Alzheimer’s found to improve cognition in trial

Alzheimer's News Today

Oral Anti-Amyloid Shows Disease-Modifying Potential: Phase 2 Data

Medscape

The New Era of Life Sciences

Newsweek

Why lecanemab’s success spells the revival of small-molecule Alzheimer’s treatments

c&en